Target intelligence / Profile preview

Proline rich 23 domain containing 1 pseudogene

Molecular classification
Other (pseudogene)
01

Overview

Proline rich 23 domain containing 1 pseudogene" is a genomic DNA segment that has sequence similarity to the functional PRR23 gene family but is classified as a **pseudogene**, which means it is generally regarded as nonfunctional and does not produce a functional protein[4]. Pseudogenes arise through duplication or retrotransposition of protein-coding genes, but usually accumulate disabling mutations that render them transcriptionally inactive or incapable of translation. There is no evidence supporting a functional or pathological role for this pseudogene, and it is not a molecular target in drug discovery or therapy. Pseudogenes are typically not expressed as proteins and lack regulatory features necessary for normal gene function[4]. Some pseudogenes may exhibit low-level transcription, or in rare cases, regulatory roles (e.g., as non-coding RNAs), but for ENSG00000285862 specifically, there is no such evidence or functional annotation[4][2]. PRR23D3P is a related pseudogene from the gene family but is distinct (and still classified as a pseudogene with no function or disease association)[3]. No drugs, biomarkers, or mechanisms of action are linked to this entity. If your intention was to identify a druggable receptor or enzyme, this entry does not represent such a target, and its use as a therapeutic endpoint is incorrect.

Beyond the preview

Go deeper on Proline rich 23 domain containing 1 pseudogene.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Proline rich 23 domain containing 1 pseudogene.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call